Tetracosactide (cosyntropin recalls

The FDA has published 1 recall involving Tetracosactide (cosyntropin since 2012. The latest was reported on 22 Aug 2012. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 22 Aug 2012

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why tetracosactide (cosyntropin is recalled

Sterility1100%

Companies

Franck's Lab Inc., d.b.a. Franck's Compounding Lab1100%

By year

20121100%

All tetracosactide (cosyntropin recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Aug 2012Drug	CLASS II	Tetracosactide Acetate (cosyntropin) 0.25mg/ML Injectable recalled	Franck's Lab Inc., d.b.a. Franck's Compounding Lab	Sterility	Nationwide

Should you stop taking Tetracosactide (cosyntropin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.